Shanghai Fosun Pharmaceutical (600196.SH) plans to repurchase A-shares worth 300 million to 600 million yuan.

22/01/2025

GMT Eight

Shanghai Fosun Pharmaceutical (600196.SH) announced that the company plans to repurchase A-shares worth 300 million to 600 million yuan, with a maximum repurchase price of 30 yuan per share, to be used for the future conversion of convertible bonds, and/or implementation of equity incentive plans and/or employee stock plans.

Cloud Live Technology Group (002306.SZ) predicts a net loss of 18-22 million yuan for the year 2024.

Changzhou Architectural Research Institute Group (301115.SZ) issued a profit warning, expecting a net profit of 10-15 million yuan for the 2024 fiscal year, a year-on-year decrease of 85.09%-90.06%.

Contact: contact@gmteight.com

Shanghai Fosun Pharmaceutical (600196.SH) plans to repurchase A-shares worth 300 million to 600 million yuan.

RECOMMEND

US Stock Market Move | Q4 earnings per share exceeded expectations, Anheuser-Busch InBev (APH.US) rose over 6%, reaching a new all-time high.

US Stock Market Move | AI concept stocks perform strongly, Arm Holdings (ARM.US) rises more than 14%.

US Stock Market Move | The Nasdaq broke through the 20,000-point mark in intraday trading, with NVIDIA Corporation (NVDA.US) rising more than 4%.